Toxic serum levels of tacrolimus after topical administration in an infant with severe cutaneous graft-versus-host disease.
Prot-Labarthe
S
S
Therrien
R
R
Champagne
M A
MA
Duval
M
M
Joubert
C
C
D000279:Administration, Cutaneous; D000284:Administration, Oral; D036101:Cord Blood Stem Cell Transplantation; D064420:Drug-Related Side Effects and Adverse Reactions; D006086:Graft vs Host Disease / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D007223:Infant; D008297:Male; D016511:Severe Combined Immunodeficiency / Q000097:blood / Q000150:complications / Q000628:therapy; D012871:Skin Diseases / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D016559:Tacrolimus / Q000008:administration & dosage / Q000493:pharmacokinetics*; D013997:Time Factors; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D016559:Tacrolimus